查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1830962

蛋白质体学市场

Proteomics Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

蛋白质体学市场预计将大幅成长，预计将从 2024 年的 345.6 亿美元成长到 2031 年的 859.1 亿美元，2025 年至 2031 年的复合年增长率为 11.9%。

分析师观点：本报告概述了基于蛋白质组学市场当前趋势及其在预测期内的预期影响的成长机会。蛋白质体学涉及对蛋白质组的广泛研究，蛋白质组是由生物体产生的蛋白质的集合。蛋白质组是动态的，在不同细胞之间有所不同，并随时间而变化。它提供了对底层转录组的深入了解，转录组涵盖了生物体中的所有信使RNA分子。除了基因表现量之外，还有许多因素会影响蛋白质活性。蛋白质体学的应用非常广泛，由于个人化医疗需求的不断增长以及该领域研发的不断增加，预计市场将大幅扩张。然而，严格的监管要求和熟练专业人员的短缺可能会阻碍市场成长。

市场概览：蛋白质体学是对蛋白质结构和功能的综合研究。它包括快速发展的疾病蛋白质组学领域，该领域旨在识别与人类疾病相关的蛋白质，并了解其表达、结构和功能如何导致疾病。蛋白质体学市场成长的关键驱动因素包括癌症和其他疾病发生率的上升。正在进行的蛋白质组学研究透过提供关键的生物标记信息，帮助医疗保健专业人员了解蛋白质在动态环境中的行为，例如在癌症患者体内。此外，奈米蛋白质组学的进步预计将在未来几年对市场成长产生积极影响。

策略洞察市场驱动因素：慢性病发生率上升推动市场扩张。癌症、呼吸系统疾病、慢性肾臟病 (CKD) 和心血管疾病 (CVD) 等慢性病的盛行率不断上升，预计将成为推动市场成长的重要因素。例如，Globocan 报告称，2020 年 12 月全球新增癌症病例约 1,930 万例，癌症相关死亡人数达 1,000 万人。心血管疾病也是全球主要死因之一，世界卫生组织 (WHO) (2021) 指出，这些疾病每年造成 4,100 万人死亡。危及生命的疾病发病率不断上升，推动了对个人化治疗的需求，这对该行业产生了积极影响。

随着全球人口中很大一部分与癌症作斗争，对有效治疗的需求激增。生命科学领域正在取得许多突破，人类蛋白质的表征标誌着生物医学的重大进步。在蛋白质组层面评估基因表现至关重要。该领域的持续研发预计将推动蛋白质体学市场的大幅成长，因为这项技术可以提供重要的生物学见解，增强我们对癌症生物学的理解。慢性病盛行率的上升进一步扩大了对蛋白质体学的需求。

分段分析：透过检查以下分段来分析蛋白质体学市场：产品和服务、应用和最终用户。

就产品和服务而言，蛋白质体学市场分为仪器技术、试剂和耗材以及软体和服务。试剂和耗材细分市场在2022年占据市场主导地位，预计在2022年至2030年期间将达到14.1%的最高复合年增长率。这一增长归因于研究机构和大学在研究各种生物材料时对试剂、试剂盒、耗材和试纸的使用日益增加。此外，政府支持蛋白质组学和基因组学的倡议，以及疾病诊断研究活动的加强，预计将推动市场成长。此外，3D电泳蛋白分析仪等先进仪器的进步，提高了生物研究的速度、效率和生产力，也将有助于市场扩张。

根据应用，市场细分为临床诊断、药物研发和其他领域。临床诊断领域在2022年占据了蛋白质体学市场的最大份额，因为研究人员和临床医生经常利用蛋白质分析来识别疾病生物标记物，从而进行早期风险因素检测。基于蛋白质体学的诊断方法还可以揭示潜在的蛋白质转录调控，有助于恶性肿瘤的识别和预后。

就最终用户而言，蛋白质体学市场分为製药和生物技术公司、研究和临床实验室、医院和其他。製药和生物技术公司在2022年占据了最大的市场份额。然而，预计研究和临床实验室在2022年至2030年期间的复合年增长率最高，为14.5%。製药和生物技术公司为开发创新药物而增加的研发资金可能会推动对蛋白质体学服务的需求。此外，研发活动的加强、针对各种危及生命疾病的蛋白质体学研究的持续进行以及学术和研究环境中生命科学计画的增加，也推动了对酵素、试剂和试剂盒的需求。

区域分析：蛋白质体学市场报告涵盖北美、欧洲、亚太地区、中东和非洲以及南美和中美。北美市场在 2022 年的价值为 119.5 亿美元，预计到 2030 年将达到 335.6 亿美元，2022 年至 2030 年的复合年增长率为 13.8%。推动该地区市场成长的关键因素包括对基于结构的药物设计投资的增加、对高品质资料可重复性研究工具的需求以及组学研究的成长。人们专注于开发个人化治疗，主要区域公司之间的合作也有助于扩大市场。例如，赛默飞世尔科技公司和 Symphogen 合作创建了经过验证的平台流程，用于优化复杂治疗蛋白质的表征和品质监测。目前，许多蛋白质疗法正在进行癌症、感染、免疫疾病、与年龄相关的疾病和其他疾病的临床试验。此外，由于美国阿兹海默症等遗传疾病以及疟疾和结核病等传染病的高发病率，蛋白质体学研究在美国蓬勃发展。

亚太地区蛋白质体学市场预计将实现最快的复合年增长率，达到14.3%。该地区，尤其是印度和中国等国家，拥有庞大的製药产业，而中国则是製药製造中心。该地区预期的市场成长得益于其拥有功能齐全的製造部门和合约製造设施。此外，大量易患癌症和其他传染病的人群、蛋白质体学在诊断遗传疾病中的广泛应用以及研发支出和社会项目的增加，预计将推动基于蛋白质组的疾病诊断需求，从而促进市场成长。

蛋白质体学市场报告范围关键参与者分析：蛋白质组学市场报告中介绍的关键参与者包括 Proteome Sciences、Biognosys、Creative Proteomics、Shantani、Olink、SomaLogic Operating Co., Inc.、QUANTUM-SI INCORPORATED、Proteomics International、Promise Proteomics、SCII.

最新动态：蛋白质体学市场中的公司正在将併购作为关键的成长策略。市场的最新动态包括：

2022年6月，SomaLogic与Illumina公司宣布达成联合开发协议，将在Illumina现有及未来的高通量新一代定序(NGS)平台上应用SomaScan蛋白质组学检测试剂盒，加速快速增长的蛋白质组学市场中新一代定序技术的发展。 2022年5月，Proteomics International Laboratories Ltd获得13,516美元融资，用于在澳洲生产其PromarkerD临床诊断试剂盒，这是第一个针对糖尿病相关肾病变的诊断预测检测。该计划旨在促进新的健康创新，推动相关发现向概念验证和商业化方向发展，从而应对重大健康挑战，并最大限度地发挥创业潜力。

目录

第一章：引言

第二章：关键要点

第三章：研究方法

第四章：蛋白质体学市场格局

  • 概述
  • 害虫分析
    • 北美 - 害虫分析
    • 欧洲 - 害虫分析
    • 亚太地区 - 害虫分析
    • 中东和非洲 - 害虫分析
    • 南美洲和中美洲 - 害虫分析
  • 专家意见

第五章：蛋白质体学市场－主要市场动态

  • 主要市场驱动因素
  • 主要市场限制因素
  • 主要市场机会
  • 未来趋势
  • 驱动因素和约束因素的影响分析

第六章：蛋白质体学市场－全球市场分析

  • 蛋白质体学—全球市场概览
  • 蛋白质体学－全球市场及2028年预测
  • 市场定位

第七章：蛋白质体学市场－2028 年营收及预测－仪器

  • 概述
  • 仪器市场预测与分析
  • 光谱学
    • 概述
    • 光谱市场预测与分析
    • 质谱市场
      • 概述
      • 质谱市场预测与分析
    • 核磁共振光谱市场
      • 概述
      • 核磁共振光谱市场预测与分析
    • 圆二色性（CD）光谱市场
      • 概述
      • 圆二色性（CD）光谱市场预测与分析
  • 色谱法
    • 概述
    • 色谱市场预测与分析
    • HPLC市场
      • 概述
      • HPLC市场预测与分析
    • 离子色谱市场
      • 概述
      • 离子色谱市场预测与分析
    • 离子色谱市场
      • 概述
      • 离子色谱市场预测与分析
    • 超临界流体层析市场
      • 概述
      • 超临界流体色谱市场预测与分析
  • 电泳
    • 概述
    • 电泳市场预测与分析
    • 凝胶电泳市场
      • 概述
      • 凝胶电泳市场预测与分析
    • 毛细管电泳市场
      • 概述
      • 毛细管电泳市场预测与分析
  • 蛋白质微阵列
    • 概述
    • 蛋白质微阵列市场预测与分析
    • 生物晶片市场
      • 概述
      • 生物晶片市场预测与分析
    • 微阵列仪器市场
      • 概述
      • 微阵列仪器市场预测与分析
  • X射线晶体学
    • 概述
    • X射线晶体学市场预测与分析
  • 表面等离子体共振
    • 概述
    • 表面等离子体共振市场预测与分析
  • 蛋白质分馏
    • 概述
    • 蛋白质分馏市场预测与分析
  • 其他乐器
    • 概述
    • 其他仪器市场预测与分析

第 8 章：蛋白质体学市场 - 收入与预测（至 2028 年）- 试剂

  • 概述
  • 试剂市场预测与分析
  • 免疫分析试剂
    • 概述
    • 免疫分析试剂市场预测与分析
  • 光谱试剂
    • 概述
    • 光谱试剂市场预测与分析
  • 色谱试剂
    • 概述
    • 色谱试剂市场预测与分析
  • 蛋白质微阵列试剂
    • 概述
    • 蛋白质微阵列试剂市场预测与分析
  • X射线晶体学试剂
    • 概述
    • X射线晶体学试剂市场预测与分析
  • 电泳试剂
    • 概述
    • 电泳试剂市场预测与分析
  • 蛋白质分离试剂
    • 概述
    • 蛋白质分离试剂市场预测与分析

第九章：蛋白质体学市场－2028年营收及预测－服务与软体

  • 概述
  • 服务与软体市场预测与分析
  • 服务
    • 概述
    • 服务市场预测与分析
    • 蛋白质鑑定服务市场
      • 概述
      • 蛋白质鑑定服务市场预测与分析
    • 定量蛋白质体学服务市场
      • 概述
      • 定量蛋白质体学服务市场预测与分析
    • 蛋白质纯化服务市场
      • 概述
      • 蛋白质纯化服务市场预测与分析
    • 蛋白质分离服务市场
      • 概述
      • 蛋白质分离服务市场预测与分析
    • 蛋白质定序服务市场
      • 概述
      • 蛋白质定序服务市场预测与分析
    • 其他服务市场
      • 概述
      • 其他服务市场预测与分析
  • 软体
    • 概述
    • 软体市场预测与分析
    • 生物资讯服务市场
      • 概述
      • 生物资讯服务市场预测与分析
    • 生物资讯工具市场
      • 概述
      • 生物资讯工具市场预测与分析
    • 生物资讯资料库市场
      • 概述
      • 生物资讯资料库市场预测与分析

第 10 章：蛋白质体学市场 - 收入和预测至 2028 年 - 应用

  • 概述
  • 应用市场预测与分析
  • 临床诊断
    • 概述
    • 临床诊断市场预测与分析
  • 药物研发
    • 概述
    • 药物研发市场预测与分析
  • 其他应用
    • 概述
    • 其他应用市场预测与分析

第 11 章：蛋白质体学市场收入和预测到 2028 年 - 地理分析

  • 北美洲
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 欧洲
      • 德国
      • 法国
      • 义大利
      • 西班牙
      • 英国
      • 欧洲其他地区
  • 亚太
    • 亚太
      • 澳洲
      • 中国
      • 印度
      • 日本
      • 韩国
      • 亚太其他地区
  • 中东和非洲
    • 中东和非洲
      • 南非
      • 沙乌地阿拉伯
      • 阿联酋
      • 中东和非洲其他地区
  • 南美洲和中美洲
    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区

第 12 章：COVID-19 大流行对全球蛋白质体学市场的影响

  • 北美洲
  • 欧洲
  • 亚太
  • 中东和非洲
  • 南美洲和中美洲

第十三章：产业格局

  • 併购
  • 协议、合作和合资企业
  • 新产品发布
  • 扩张和其他策略发展

第 14 章：蛋白质体学市场、主要公司简介

  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • AGILENT TECHNOLOGIES
  • DANAHER
  • PERKINELMER INC.
  • MERCK KGAA
  • LUMINEX CORPORATION
  • GENERAL ELECTRIC COMPANY
简介目录
Product Code: TIPHE100001115

The proteomics market is anticipated to grow significantly, with projections indicating an increase from US$ 34.56 billion in 2024 to US$ 85.91 billion by 2031, reflecting a CAGR of 11.9% from 2025 to 2031.

Analyst Perspective:This report outlines growth opportunities based on current trends in the proteomics market and their expected effects during the forecast period. Proteomics involves the extensive study of proteomes, which are collections of proteins produced by a biological entity. A proteome is dynamic, varying from one cell to another and changing over time. It provides insights into the underlying transcriptome, which encompasses all messenger RNA molecules in an organism. Various factors, beyond just gene expression levels, affect protein activity. The applications of proteomics are vast, and the market is projected to expand significantly due to rising demand for personalized medicine and increased research and development in the field. However, stringent regulatory requirements and a shortage of skilled professionals may hinder market growth.

Market Overview:Proteomics is the comprehensive study of protein structures and functions. It includes the rapidly advancing area of disease proteomics, which seeks to identify proteins associated with human diseases and understand how their expression, structure, and function contribute to disease. Key drivers of growth in the proteomics market include the rising incidence of cancer and other diseases. Ongoing proteomics research aids healthcare professionals in understanding protein behavior in dynamic environments, such as in cancer patients, by providing critical biomarker information. Moreover, advancements in nano proteomics are expected to positively influence market growth in the coming years.

Strategic Insights Market Driver: Rising Incidence of Chronic Diseases Fuels Market Expansion

The increasing prevalence of chronic diseases, including cancer, respiratory illnesses, chronic kidney disease (CKD), and cardiovascular diseases (CVDs), is a significant factor anticipated to drive market growth. For instance, Globocan reported approximately 19.3 million new cancer cases globally in December 2020, with 10 million cancer-related deaths. Cardiovascular diseases are also among the leading causes of death worldwide, with the WHO (2021) noting that these diseases account for 41 million deaths annually. The rising incidence of life-threatening diseases is driving demand for personalized therapies, which positively impacts the industry.

As a significant portion of the global population battles cancer, the demand for effective treatments has surged. Numerous breakthroughs are being made in life sciences, with the characterization of human proteins marking a significant advancement in biomedicine. Evaluating gene expression at the proteome level is crucial. Ongoing research and development in this area are expected to lead to substantial growth in the proteomics market, as this technique can yield vital biological insights that enhance our understanding of cancer biology. The increasing prevalence of chronic diseases further amplifies the demand for proteomics.

Segmental Analysis:The analysis of the proteomics market has been conducted by examining the following segments: product & service, application, and end user.

In terms of product & service, the proteomics market is categorized into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment dominated the market in 2022 and is projected to achieve the highest CAGR of 14.1% from 2022 to 2030. This growth is attributed to the increasing utilization of reagents, kits, consumables, and strips for studying various biological materials in research institutions and universities. Additionally, government initiatives supporting proteomics and genomics, along with heightened research activities in disease diagnostics, are expected to drive market growth. Furthermore, advancements in sophisticated instruments, such as 3D electrophoresis protein analyzers, which enhance the speed, efficiency, and productivity of biological research, will also contribute to market expansion.

By application, the market is segmented into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest share of the proteomics market in 2022, as researchers and clinicians frequently utilize protein analysis to identify disease biomarkers for early risk factor detection. Proteomics-based diagnostics can also uncover potential protein transcription regulation, aiding in the identification and prognosis of malignancies.

Regarding end users, the proteomics market is divided into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, and others. The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2022. However, the research & clinical laboratories segment is expected to experience the highest CAGR of 14.5% from 2022 to 2030. Increased R&D funding from pharmaceutical and biotechnology firms aimed at developing innovative drugs is likely to drive demand for proteomics services. Additionally, the need for enzymes, reagents, and kits is being fueled by heightened research and development activities, ongoing proteomics studies targeting various life-threatening diseases, and increased life science projects in academic and research settings.

Regional Analysis:The proteomics market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North American market was valued at US$ 11.95 billion in 2022 and is projected to reach US$ 33.56 billion by 2030, with an expected CAGR of 13.8% from 2022 to 2030. Key factors driving market growth in this region include increased investments in structure-based drug design, demand for high-quality research tools for data reproducibility, and growth in omics research. There is a focus on developing personalized treatments, and partnerships among major regional companies also contribute to market expansion. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to create verified platform processes for the optimized characterization and quality monitoring of complex therapeutic proteins. Numerous protein therapies are currently undergoing clinical trials for cancer, infections, immunological disorders, age-related diseases, and other conditions. Additionally, proteomics research is thriving in the US, driven by the high incidence of inherited diseases like Alzheimer's and infectious diseases such as malaria and tuberculosis in the region.

The Asia Pacific proteomics market is expected to exhibit the fastest CAGR of 14.3%. This region, particularly countries like India and China, boasts a substantial pharmaceutical industry, with China serving as a hub for pharmaceutical manufacturing. The anticipated market growth in this region is attributed to the presence of highly functional manufacturing units and contract manufacturing facilities. Furthermore, a large population susceptible to cancer and other infectious diseases, extensive use of proteomics in diagnosing genetic disorders, and increased R&D spending and social programs are expected to drive the demand for proteome-based disease diagnosis, thereby enhancing market growth.

Proteomics Market Report Scope Key Player Analysis:Key players profiled in the proteomics market report include Proteome Sciences, Biognosys, Creative Proteomics, Shantani, Olink, SomaLogic Operating Co., Inc., QUANTUM-SI INCORPORATED, Proteomics International, Promise Proteomics, SCIEX, Illumina, Inc., and Thermo Fisher Scientific Inc.

Recent Developments:Companies in the proteomics market are pursuing mergers and acquisitions as key growth strategies. Recent developments in the market include:

In June 2022, SomaLogic and Illumina, Inc. announced a joint development agreement to utilize the SomaScan Proteomics Assay on Illumina's current and future high-throughput next-generation sequencing (NGS) platforms, accelerating next-generation sequencing in the rapidly growing proteomics market.

In May 2022, Proteomics International Laboratories Ltd secured US$ 13,516 in funding to facilitate the production of its PromarkerD clinical diagnostic in Australia, the first diagnostic predictive test for diabetes-related kidney disease. This initiative aims to foster new health innovations and advance discoveries toward proof-of-concept and commercialization that address significant health challenges and maximize entrepreneurial potential.

Table Of Contents

1. INTRODUCTION

  • 1.1. SCOPE OF THE STUDY
  • 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
  • 1.3. MARKET SEGMENTATION
    • 1.3.1 Proteomics Market - By Instrument
    • 1.3.2 Proteomics Market - By Reagents
    • 1.3.3 Proteomics Market - By Services and Software
    • 1.3.4 Proteomics Market - By Application
    • 1.3.5 Proteomics Market - By Region
      • 1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROTEOMICS MARKET LANDSCAPE

  • 4.1. OVERVIEW
  • 4.2. PEST ANALYSIS
    • 4.2.1 North America - Pest Analysis
    • 4.2.2 Europe - Pest Analysis
    • 4.2.3 Asia-Pacific - Pest Analysis
    • 4.2.4 Middle East and Africa - Pest Analysis
    • 4.2.5 South and Central America - Pest Analysis
  • 4.3. EXPERT OPINIONS

5. PROTEOMICS MARKET - KEY MARKET DYNAMICS

  • 5.1. KEY MARKET DRIVERS
  • 5.2. KEY MARKET RESTRAINTS
  • 5.3. KEY MARKET OPPORTUNITIES
  • 5.4. FUTURE TRENDS
  • 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROTEOMICS MARKET - GLOBAL MARKET ANALYSIS

  • 6.1. PROTEOMICS - GLOBAL MARKET OVERVIEW
  • 6.2. PROTEOMICS - GLOBAL MARKET AND FORECAST TO 2028
  • 6.3. MARKET POSITIONING

7. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - INSTRUMENT

  • 7.1. OVERVIEW
  • 7.2. INSTRUMENT MARKET FORECASTS AND ANALYSIS
  • 7.3. SPECTROSCOPY
    • 7.3.1. Overview
    • 7.3.2. Spectroscopy Market Forecast and Analysis
    • 7.3.3. Mass Spectroscopy Market
      • 7.3.3.1. Overview
      • 7.3.3.2. Mass Spectroscopy Market Forecast and Analysis
    • 7.3.4. NMR Spectroscopy Market
      • 7.3.4.1. Overview
      • 7.3.4.2. NMR Spectroscopy Market Forecast and Analysis
    • 7.3.5. Circular Dichroism (CD) Spectroscopy Market
      • 7.3.5.1. Overview
      • 7.3.5.2. Circular Dichroism (CD) Spectroscopy Market Forecast and Analysis
  • 7.4. CHROMATOGRAPHY
    • 7.4.1. Overview
    • 7.4.2. Chromatography Market Forecast and Analysis
    • 7.4.3. HPLC Market
      • 7.4.3.1. Overview
      • 7.4.3.2. HPLC Market Forecast and Analysis
    • 7.4.4. Ion Chromatography Market
      • 7.4.4.1. Overview
      • 7.4.4.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.5. Ion Chromatography Market
      • 7.4.5.1. Overview
      • 7.4.5.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.6. Supercritical Fluid Chromatography Market
      • 7.4.6.1. Overview
      • 7.4.6.2. Supercritical Fluid Chromatography Market Forecast and Analysis
  • 7.5. ELECTROPHORESIS
    • 7.5.1. Overview
    • 7.5.2. Electrophoresis Market Forecast and Analysis
    • 7.5.3. Gel Electrophoresis Market
      • 7.5.3.1. Overview
      • 7.5.3.2. Gel Electrophoresis Market Forecast and Analysis
    • 7.5.4. Capillary Electrophoresis Market
      • 7.5.4.1. Overview
      • 7.5.4.2. Capillary Electrophoresis Market Forecast and Analysis
  • 7.6. PROTEIN MICROARRAYS
    • 7.6.1. Overview
    • 7.6.2. Protein Microarrays Market Forecast and Analysis
    • 7.6.3. Biochips Market
      • 7.6.3.1. Overview
      • 7.6.3.2. Biochips Market Forecast and Analysis
    • 7.6.4. Microarray Instruments Market
      • 7.6.4.1. Overview
      • 7.6.4.2. Microarray Instruments Market Forecast and Analysis
  • 7.7. X-RAY CRYSTALLOGRAPHY
    • 7.7.1. Overview
    • 7.7.2. X-Ray Crystallography Market Forecast and Analysis
  • 7.8. SURFACE PLASMON RESONANCE
    • 7.8.1. Overview
    • 7.8.2. Surface Plasmon Resonance Market Forecast and Analysis
  • 7.9. PROTEIN FRACTIONATION
    • 7.9.1. Overview
    • 7.9.2. Protein Fractionation Market Forecast and Analysis
  • 7.10. OTHER INSTRUMENT
    • 7.10.1. Overview
    • 7.10.2. Other Instrument Market Forecast and Analysis

8. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS

  • 8.1. OVERVIEW
  • 8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
  • 8.3. IMMUNOASSAY REAGENTS
    • 8.3.1. Overview
    • 8.3.2. Immunoassay Reagents Market Forecast and Analysis
  • 8.4. SPECTROSCOPY REAGENTS
    • 8.4.1. Overview
    • 8.4.2. Spectroscopy Reagents Market Forecast and Analysis
  • 8.5. CHROMATOGRAPHY REAGENTS
    • 8.5.1. Overview
    • 8.5.2. Chromatography Reagents Market Forecast and Analysis
  • 8.6. PROTEIN MICROARRAY REAGENTS
    • 8.6.1. Overview
    • 8.6.2. Protein Microarray Reagents Market Forecast and Analysis
  • 8.7. X-RAY CRYSTALLOGRAPHY REAGENTS
    • 8.7.1. Overview
    • 8.7.2. X-Ray Crystallography Reagents Market Forecast and Analysis
  • 8.8. ELECTROPHORESIS REAGENTS
    • 8.8.1. Overview
    • 8.8.2. Electrophoresis Reagents Market Forecast and Analysis
  • 8.9. PROTEIN FRACTIONATION REAGENTS
    • 8.9.1. Overview
    • 8.9.2. Protein Fractionation Reagents Market Forecast and Analysis

9. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES AND SOFTWARE

  • 9.1. OVERVIEW
  • 9.2. SERVICES AND SOFTWARE MARKET FORECASTS AND ANALYSIS
  • 9.3. SERVICES
    • 9.3.1. Overview
    • 9.3.2. Services Market Forecast and Analysis
    • 9.3.3. Protein Identification Services Market
      • 9.3.3.1. Overview
      • 9.3.3.2. Protein Identification Services Market Forecast and Analysis
    • 9.3.4. Quantitative Proteomics Services Market
      • 9.3.4.1. Overview
      • 9.3.4.2. Quantitative Proteomics Services Market Forecast and Analysis
    • 9.3.5. Protein Purification Services Market
      • 9.3.5.1. Overview
      • 9.3.5.2. Protein Purification Services Market Forecast and Analysis
    • 9.3.6. Protein Separation Services Market
      • 9.3.6.1. Overview
      • 9.3.6.2. Protein Separation Services Market Forecast and Analysis
    • 9.3.7. Protein Sequencing Services Market
      • 9.3.7.1. Overview
      • 9.3.7.2. Protein Sequencing Services Market Forecast and Analysis
    • 9.3.8. Others Services Market
      • 9.3.8.1. Overview
      • 9.3.8.2. Others Services Market Forecast and Analysis
  • 9.4. SOFTWARE
    • 9.4.1. Overview
    • 9.4.2. Software Market Forecast and Analysis
    • 9.4.3. Bioinformatics Services Market
      • 9.4.3.1. Overview
      • 9.4.3.2. Bioinformatics Services Market Forecast and Analysis
    • 9.4.4. Bioinformatics Tools Market
      • 9.4.4.1. Overview
      • 9.4.4.2. Bioinformatics Tools Market Forecast and Analysis
    • 9.4.5. Bioinformatics Databases Market
      • 9.4.5.1. Overview
      • 9.4.5.2. Bioinformatics Databases Market Forecast and Analysis

10. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION

  • 10.1. OVERVIEW
  • 10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
  • 10.3. CLINICAL DIAGNOSTICS
    • 10.3.1. Overview
    • 10.3.2. Clinical Diagnostics Market Forecast and Analysis
  • 10.4. DRUG DISCOVERY
    • 10.4.1. Overview
    • 10.4.2. Drug Discovery Market Forecast and Analysis
  • 10.5. OTHER APPLICATIONS
    • 10.5.1. Overview
    • 10.5.2. Other Applications Market Forecast and Analysis

11. PROTEOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1 North America Proteomics Market Overview
    • 11.1.2 North America Proteomics Market Forecasts and Analysis
    • 11.1.3 North America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.1.4 North America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.1.5 North America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.1.6 North America Proteomics Market Forecasts and Analysis - By Application
    • 11.1.7 North America Proteomics Market Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Proteomics Market
        • 11.1.7.1.1 United States Proteomics Market by Instrument
        • 11.1.7.1.2 United States Proteomics Market by Reagents
        • 11.1.7.1.3 United States Proteomics Market by Services and Software
        • 11.1.7.1.4 United States Proteomics Market by Application
      • 11.1.7.2 Canada Proteomics Market
        • 11.1.7.2.1 Canada Proteomics Market by Instrument
        • 11.1.7.2.2 Canada Proteomics Market by Reagents
        • 11.1.7.2.3 Canada Proteomics Market by Services and Software
        • 11.1.7.2.4 Canada Proteomics Market by Application
      • 11.1.7.3 Mexico Proteomics Market
        • 11.1.7.3.1 Mexico Proteomics Market by Instrument
        • 11.1.7.3.2 Mexico Proteomics Market by Reagents
        • 11.1.7.3.3 Mexico Proteomics Market by Services and Software
        • 11.1.7.3.4 Mexico Proteomics Market by Application
  • 11.2. EUROPE
    • 11.2.1 Europe Proteomics Market Overview
    • 11.2.2 Europe Proteomics Market Forecasts and Analysis
    • 11.2.3 Europe Proteomics Market Forecasts and Analysis - By Instrument
    • 11.2.4 Europe Proteomics Market Forecasts and Analysis - By Reagents
    • 11.2.5 Europe Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.2.6 Europe Proteomics Market Forecasts and Analysis - By Application
    • 11.2.7 Europe Proteomics Market Forecasts and Analysis - By Countries
      • 11.2.7.1 Germany Proteomics Market
        • 11.2.7.1.1 Germany Proteomics Market by Instrument
        • 11.2.7.1.2 Germany Proteomics Market by Reagents
        • 11.2.7.1.3 Germany Proteomics Market by Services and Software
        • 11.2.7.1.4 Germany Proteomics Market by Application
      • 11.2.7.2 France Proteomics Market
        • 11.2.7.2.1 France Proteomics Market by Instrument
        • 11.2.7.2.2 France Proteomics Market by Reagents
        • 11.2.7.2.3 France Proteomics Market by Services and Software
        • 11.2.7.2.4 France Proteomics Market by Application
      • 11.2.7.3 Italy Proteomics Market
        • 11.2.7.3.1 Italy Proteomics Market by Instrument
        • 11.2.7.3.2 Italy Proteomics Market by Reagents
        • 11.2.7.3.3 Italy Proteomics Market by Services and Software
        • 11.2.7.3.4 Italy Proteomics Market by Application
      • 11.2.7.4 Spain Proteomics Market
        • 11.2.7.4.1 Spain Proteomics Market by Instrument
        • 11.2.7.4.2 Spain Proteomics Market by Reagents
        • 11.2.7.4.3 Spain Proteomics Market by Services and Software
        • 11.2.7.4.4 Spain Proteomics Market by Application
      • 11.2.7.5 United Kingdom Proteomics Market
        • 11.2.7.5.1 United Kingdom Proteomics Market by Instrument
        • 11.2.7.5.2 United Kingdom Proteomics Market by Reagents
        • 11.2.7.5.3 United Kingdom Proteomics Market by Services and Software
        • 11.2.7.5.4 United Kingdom Proteomics Market by Application
      • 11.2.7.6 Rest of Europe Proteomics Market
        • 11.2.7.6.1 Rest of Europe Proteomics Market by Instrument
        • 11.2.7.6.2 Rest of Europe Proteomics Market by Reagents
        • 11.2.7.6.3 Rest of Europe Proteomics Market by Services and Software
        • 11.2.7.6.4 Rest of Europe Proteomics Market by Application
  • 11.3. ASIA-PACIFIC
    • 11.3.1 Asia-Pacific Proteomics Market Overview
    • 11.3.2 Asia-Pacific Proteomics Market Forecasts and Analysis
    • 11.3.3 Asia-Pacific Proteomics Market Forecasts and Analysis - By Instrument
    • 11.3.4 Asia-Pacific Proteomics Market Forecasts and Analysis - By Reagents
    • 11.3.5 Asia-Pacific Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.3.6 Asia-Pacific Proteomics Market Forecasts and Analysis - By Application
    • 11.3.7 Asia-Pacific Proteomics Market Forecasts and Analysis - By Countries
      • 11.3.7.1 Australia Proteomics Market
        • 11.3.7.1.1 Australia Proteomics Market by Instrument
        • 11.3.7.1.2 Australia Proteomics Market by Reagents
        • 11.3.7.1.3 Australia Proteomics Market by Services and Software
        • 11.3.7.1.4 Australia Proteomics Market by Application
      • 11.3.7.2 China Proteomics Market
        • 11.3.7.2.1 China Proteomics Market by Instrument
        • 11.3.7.2.2 China Proteomics Market by Reagents
        • 11.3.7.2.3 China Proteomics Market by Services and Software
        • 11.3.7.2.4 China Proteomics Market by Application
      • 11.3.7.3 India Proteomics Market
        • 11.3.7.3.1 India Proteomics Market by Instrument
        • 11.3.7.3.2 India Proteomics Market by Reagents
        • 11.3.7.3.3 India Proteomics Market by Services and Software
        • 11.3.7.3.4 India Proteomics Market by Application
      • 11.3.7.4 Japan Proteomics Market
        • 11.3.7.4.1 Japan Proteomics Market by Instrument
        • 11.3.7.4.2 Japan Proteomics Market by Reagents
        • 11.3.7.4.3 Japan Proteomics Market by Services and Software
        • 11.3.7.4.4 Japan Proteomics Market by Application
      • 11.3.7.5 South Korea Proteomics Market
        • 11.3.7.5.1 South Korea Proteomics Market by Instrument
        • 11.3.7.5.2 South Korea Proteomics Market by Reagents
        • 11.3.7.5.3 South Korea Proteomics Market by Services and Software
        • 11.3.7.5.4 South Korea Proteomics Market by Application
      • 11.3.7.6 Rest of Asia-Pacific Proteomics Market
        • 11.3.7.6.1 Rest of Asia-Pacific Proteomics Market by Instrument
        • 11.3.7.6.2 Rest of Asia-Pacific Proteomics Market by Reagents
        • 11.3.7.6.3 Rest of Asia-Pacific Proteomics Market by Services and Software
        • 11.3.7.6.4 Rest of Asia-Pacific Proteomics Market by Application
  • 11.4. MIDDLE EAST AND AFRICA
    • 11.4.1 Middle East and Africa Proteomics Market Overview
    • 11.4.2 Middle East and Africa Proteomics Market Forecasts and Analysis
    • 11.4.3 Middle East and Africa Proteomics Market Forecasts and Analysis - By Instrument
    • 11.4.4 Middle East and Africa Proteomics Market Forecasts and Analysis - By Reagents
    • 11.4.5 Middle East and Africa Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.4.6 Middle East and Africa Proteomics Market Forecasts and Analysis - By Application
    • 11.4.7 Middle East and Africa Proteomics Market Forecasts and Analysis - By Countries
      • 11.4.7.1 South Africa Proteomics Market
        • 11.4.7.1.1 South Africa Proteomics Market by Instrument
        • 11.4.7.1.2 South Africa Proteomics Market by Reagents
        • 11.4.7.1.3 South Africa Proteomics Market by Services and Software
        • 11.4.7.1.4 South Africa Proteomics Market by Application
      • 11.4.7.2 Saudi Arabia Proteomics Market
        • 11.4.7.2.1 Saudi Arabia Proteomics Market by Instrument
        • 11.4.7.2.2 Saudi Arabia Proteomics Market by Reagents
        • 11.4.7.2.3 Saudi Arabia Proteomics Market by Services and Software
        • 11.4.7.2.4 Saudi Arabia Proteomics Market by Application
      • 11.4.7.3 U.A.E Proteomics Market
        • 11.4.7.3.1 U.A.E Proteomics Market by Instrument
        • 11.4.7.3.2 U.A.E Proteomics Market by Reagents
        • 11.4.7.3.3 U.A.E Proteomics Market by Services and Software
        • 11.4.7.3.4 U.A.E Proteomics Market by Application
      • 11.4.7.4 Rest of Middle East and Africa Proteomics Market
        • 11.4.7.4.1 Rest of Middle East and Africa Proteomics Market by Instrument
        • 11.4.7.4.2 Rest of Middle East and Africa Proteomics Market by Reagents
        • 11.4.7.4.3 Rest of Middle East and Africa Proteomics Market by Services and Software
        • 11.4.7.4.4 Rest of Middle East and Africa Proteomics Market by Application
  • 11.5. SOUTH AND CENTRAL AMERICA
    • 11.5.1 South and Central America Proteomics Market Overview
    • 11.5.2 South and Central America Proteomics Market Forecasts and Analysis
    • 11.5.3 South and Central America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.5.4 South and Central America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.5.5 South and Central America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.5.6 South and Central America Proteomics Market Forecasts and Analysis - By Application
    • 11.5.7 South and Central America Proteomics Market Forecasts and Analysis - By Countries
      • 11.5.7.1 Brazil Proteomics Market
        • 11.5.7.1.1 Brazil Proteomics Market by Instrument
        • 11.5.7.1.2 Brazil Proteomics Market by Reagents
        • 11.5.7.1.3 Brazil Proteomics Market by Services and Software
        • 11.5.7.1.4 Brazil Proteomics Market by Application
      • 11.5.7.2 Argentina Proteomics Market
        • 11.5.7.2.1 Argentina Proteomics Market by Instrument
        • 11.5.7.2.2 Argentina Proteomics Market by Reagents
        • 11.5.7.2.3 Argentina Proteomics Market by Services and Software
        • 11.5.7.2.4 Argentina Proteomics Market by Application
      • 11.5.7.3 Rest of South and Central America Proteomics Market
        • 11.5.7.3.1 Rest of South and Central America Proteomics Market by Instrument
        • 11.5.7.3.2 Rest of South and Central America Proteomics Market by Reagents
        • 11.5.7.3.3 Rest of South and Central America Proteomics Market by Services and Software
        • 11.5.7.3.4 Rest of South and Central America Proteomics Market by Application

12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTEOMICS MARKET

  • 12.1 North America
  • 12.2 Europe
  • 12.3 Asia-Pacific
  • 12.4 Middle East and Africa
  • 12.5 South and Central America

13. INDUSTRY LANDSCAPE

  • 13.1. MERGERS AND ACQUISITIONS
  • 13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
  • 13.3. NEW PRODUCT LAUNCHES
  • 13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. PROTEOMICS MARKET, KEY COMPANY PROFILES

  • 14.1. THERMO FISHER SCIENTIFIC INC.
    • 14.1.1. Key Facts
    • 14.1.2. Business Description
    • 14.1.3. Products and Services
    • 14.1.4. Financial Overview
    • 14.1.5. SWOT Analysis
    • 14.1.6. Key Developments
  • 14.2. BIO-RAD LABORATORIES, INC.
    • 14.2.1. Key Facts
    • 14.2.2. Business Description
    • 14.2.3. Products and Services
    • 14.2.4. Financial Overview
    • 14.2.5. SWOT Analysis
    • 14.2.6. Key Developments
  • 14.3. AGILENT TECHNOLOGIES
    • 14.3.1. Key Facts
    • 14.3.2. Business Description
    • 14.3.3. Products and Services
    • 14.3.4. Financial Overview
    • 14.3.5. SWOT Analysis
    • 14.3.6. Key Developments
  • 14.4. DANAHER
    • 14.4.1. Key Facts
    • 14.4.2. Business Description
    • 14.4.3. Products and Services
    • 14.4.4. Financial Overview
    • 14.4.5. SWOT Analysis
    • 14.4.6. Key Developments
  • 14.5. PERKINELMER INC.
    • 14.5.1. Key Facts
    • 14.5.2. Business Description
    • 14.5.3. Products and Services
    • 14.5.4. Financial Overview
    • 14.5.5. SWOT Analysis
    • 14.5.6. Key Developments
  • 14.6. MERCK KGAA
    • 14.6.1. Key Facts
    • 14.6.2. Business Description
    • 14.6.3. Products and Services
    • 14.6.4. Financial Overview
    • 14.6.5. SWOT Analysis
    • 14.6.6. Key Developments
  • 14.7. LUMINEX CORPORATION
    • 14.7.1. Key Facts
    • 14.7.2. Business Description
    • 14.7.3. Products and Services
    • 14.7.4. Financial Overview
    • 14.7.5. SWOT Analysis
    • 14.7.6. Key Developments
  • 14.8. GENERAL ELECTRIC COMPANY
    • 14.8.1. Key Facts
    • 14.8.2. Business Description
    • 14.8.3. Products and Services
    • 14.8.4. Financial Overview
    • 14.8.5. SWOT Analysis
    • 14.8.6. Key Developments